Conference Speakers
Cultural Speakers
Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.
At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:
X
Dr. Speakers Full Name
Speaker Credentials
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization and in 2008 sat for and passed the exam administered by the International Board of Lactation Consultant Examiners. As an International Board Certified Lactation Consultant, she now
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization text text text text more name mulder first became interested in breastfeeding in the year 2000, when she became.
X
Abstract: Breastfeeding mothers may turn to formula and/or bottles for many
reasons. Some supplementing with formula by bottle when they reach out for help, and for some moms,
supplementing by alternative methods may be very overwhelming. Some moms need or choose a combination
of breast milk and formula and others may decide to give occasional or regular bottles of expressed
milk. Whatever the reason, as health care professionals helping a mother to breastfeed, it is our
job to be able to help her to reach her own personal goals even when she needs, or chooses to use,
bottles or formula. Learn about baby-led bottle feeding and why it's so important, different types
of formula, their uses and how to prepare them, and how this all fits in with the WHO code and our
code of professional conduct.
View Full Presentation Information & Scheduling
Dr. Speakers Full Name
Speaker Credentials
Speakers (5191)
Egbert Smit is Professor of Pulmonary Medicine (with emphasis on Pulmonary Oncology) at the Netherlands Cancer Institute, Department of Thoracic Oncology (since 2014) and the Department of Pulmonary Diseases of the Leiden University Medical Center in Leiden, The Netherlands. After finishing his PhD thesis involving multidisciplinary studies between medical oncology, genetics and pulmonary medicine 1990, he became a board certified pulmonologist in 1997. He has since 1986 been involved in basic research and clinical trials ranging from chemoprevention of lung cancer to treatment of advanced disease (non) small cell lung cancer. He has been principle investigator of several national and international phase II and III trials. In the last decade the focus of his research has been on translational oncology and molecular imaging. These research activities resulted in over 450 publications in peer reviewed journals and chapters in books
Published in
Speakers
Anne-Marie C. Dingemans MD, PhD is a pulmonologist and a professor of thoracic oncology. Since September 2019 she is a staff member of the department of pulmonary medicine at Erasmus Medical Center, Rotterdam, The Netherlands. Between 2004 and 2019 she was appointed as a staff member at the department of pulmonary medicine at Maastricht University Medical Center+. She received her medical degree at Maastricht University in 1994 and subsequently her PhD at VU Medical Center Amsterdam in 2000 for laboratory research on resistance to chemotherapy in lung cancer. She performed her training for respiratory physician at VU Medical Center in Amsterdam and Leiden University Medical Center. Currently she is involved in translational research on lung cancer, with special interest in neuroendocrine lung tumors, driver mutations and oligometastatic disease.
Since January 2021 she is chair of the EORTC lung cancer group. She was involved in the EORTC initiative to develop a consensus definition on synchronous oligometastatic NSCLC. She is member of IASLC, AACR, ASCO, ERS, ESMO and ETOP. She is associate editor of the Journal of Thoracic Oncology and editorial board member of the International IASLC Lung Cancer News. She has (co)-authored more than 200 publications and book chapters.
Published in
Speakers
Head Department of Respiratory Medicine ELK Thorax Center - Speaker German Cancer Society Section Thoracic Oncology - Editor in Chief Pneumologie
Published in
Speakers
Published in
Speakers
Dr. Sara Pilotto is a medical oncologist, assistant professor at Verona University Hospital Trust. Her main research areas include: i) clinical and translational research in lung cancer; ii) comprehensive approach to cancer patient, including phycological support, nutrition and physical activity; iii) methodology of clinical trials. She trained in both the national and international context, currently being member of the Lung cancer Guidelines Experts Panel of Italian Association of Medical Oncology (AIOM), of the Young investigators Lung Cancer Group of EORTC, of the ESMO Non-Metastatic NSCLC and other Thoracic Malignancies, of the ESMO Press & Media Affairs Committee and of the ESMO leadership program 2019. At Verona University Hospital Trust, she is leading the Lung Cancer Group and the FORCE (Focus On Research and CarE) Team, a multidisciplinary group, including a psychologist, a kinesiologist, and a dietitian.
Published in
Speakers
Enriqueta Felip is the Head of the Thoracic and Head and Neck Cancer Unit within the Oncology Department of Vall d'Hebron Hospital, Barcelona, Spain. Professor Felip is in charge of thoracic malignancy management, and is responsible for thoracic cancer trials undertaken by the Oncology Department. Current research lines include the optimization of chemotherapy in early-stage disease, evaluation of new agents and therapies, research into novel pharmacogenomic approaches, the integration of immunotherapeutic approaches in the treatment of lung cancer patients, and the elucidation of potential mechanisms of resistance to tyrosine-kinase inhibitors.
Dr Felip received her medical degree from the UAB, where she also completed her PhD studies in medical oncology. She has been Associate Professor at the Autonomous University of Barcelona (UAB) from 2010 to May 2019. She is nowadays, Professor of Medicine at the Universitat de Vic (UVicc-UCC). She is involved in the training of medical students, residents and particularly in mentoring fellows.
Dr Felip is currently a member of the Spanish Lung Cancer Group (SLCG) and the Spanish Society of Medical Oncology (SEOM). In October 2019, Dr. Felip was elected SEOM Vice-President for the following years 2019-2021.
Dr. Felip is also member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the International Association for the Study of Lung Cancer (IASLC). She is nowadays member of the Board of Directors of IASLC (2017-2021). Dr. Felip has been Co-chair of the 20th WCLC Congress that took place last September 2019 in Barcelona. Dr. Felip receives the 1st ESMO Women for Oncology Award in 2015.
Dr. Felip is now President of the Oncology Comission at Vall d’Hebron University Hospital and she is as member of the Scientific Advisory Committee of the Parc Tauli? Sabadell Hospital.
Dr Felip has been involved in several initiatives with scientific organizations, among them, as Subject Editor of Guidelines Working group ESMO Minimum Clinical Recommendations in lung cancer and Coordinator of the 1st ESMO Consensus Conference in lung cancer. Dr Felip is at present a member of the scientific committee of the SLCG.
Dr Felip is also author of many peer-reviewed articles and book chapters relating to the field of thoracic malignancies.
Published in
Speakers
Published in
Speakers
I am a Spanish medical oncologist, working in Thoracic Oncology. I finished my training in medical oncology in Salamanca in 2011, and then I moved to Madrid where I worked during 4 years. Between 2015 and 2020 I have been working in Gustave Roussy (France) initially as Translational Research Fellow in lung cancer Immunoncology (2015-2016), followed by a 2 years period of Clinical Fellow in the Thoracic Oncology Group (2016-2018). Between November 2018 and January 2020 I joined the Precision Medicine Group at Gustave Roussy. In 2018, I completed my PhD project about the impact of radon gas in certain molecular subtypes of lung cancer. From February 2020, I am working in the Hospital Clinic (Barcelona, Spain), and I have also joined the Translational Genomics and Targeted Therapeutics Group, led by Dr. Aleix Prat (IDIBAPS, Barcelona), as Translational Researcher. I am involved in several clinical and translational research projects focus on 3 main areas: a) biomarkers for immunotherapy, b) precision medicine, focused on liquid biopsy, and c) molecular epidemiology (radon gas in lung cancer).
Published in
Speakers
Dr. Federico Cappuzzo has been the Director of Medical Oncology at the National Cancer Institute Regina Elena in Rome. He is a member of the Italian Association in Medical Oncology (AIOM), European
Society for Medical Oncology (ESMO), American Society Clinical Oncology (ASCO) and
International Association for the Study of Lung Cancer (IASCL) and since 2006 as a Member
of the editorial board of Lung Cancer. From 2013 to 2017 he was the Chairman of the Educational Committee of IASLC. In 2006, 2009 and 2012 he received research grants from the Italian Association for Cancer Research (AIRC) on targeted therapies in lung cancer and is the author of more than 250 papers in peer-review journals, mainly in translational research in lung cancer.
Published in
Speakers
Joachim Aerts is head of department of Pulmonary Medicine of Erasmus MC Rotterdam. He is a renown expert in fundamental, translational and clinical immuno-oncology research, with a strong focus on lung cancer and mesothelioma. He has authored >200 publications and is PI of studies funded by e.g. EU Horizon2020 and ZonMw.
Published in
Speakers
